Randomized Phase II Study of Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) With or Without ImmTher for Newly Diagnosed High Risk Ewing's Sarcoma.
Phase of Trial: Phase II
Latest Information Update: 01 May 2016
At a glance
- Drugs ImmTher (Primary) ; Cyclophosphamide; Dexrazoxane; Doxorubicin; Vincristine
- Indications Ewing's sarcoma
- Focus Therapeutic Use
- 03 Mar 2016 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 06 May 2015 Planned End Date changed from 1 Nov 2015 to 1 Nov 2016 as reported by ClinicalTrials.gov record.
- 06 May 2015 Planned primary completion date changed from 1 Nov 2015 to 1 Nov 2016 as reported by ClinicalTrials.gov record.